Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Haematologica|November 5, 2020
Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphomaTiffany Tang, Peter Martin, Nagavalli Somasundaram, et al.
BMC Cancer|December 5, 2018
Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesWan-Ling Tan, Quan Sing Ng, Cindy Lim, et al.
The Journal of Clinical Endocrinology and Metabolism|July 11, 2019
IL13RA2 Is Differentially Regulated in Papillary Thyroid Carcinoma vs Follicular Thyroid CarcinomaSiao Ting Chong, Khee Ming Tan, Catherine Y L Kok, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinomaS P Choo, B Chowbay, Q S Ng, et al.
BMC Cancer|August 18, 2020
Supporting the patients with advanced cancer and their family caregivers: what are their palliative care needs?Gek Phin Chua, Grace Su Yin Pang, Alethlea Chung Pheng Yee, et al.
BMC Cancer|October 31, 2020
Randomised prospective phase II trial in multiple brain metastases comparing outcomes between hippocampal avoidance whole brain radiotherapy with or without simultaneous integrated boost: HA-SIB-WBRT study protocolBrendan Seng Hup Chia, Jing Yun Leong, Ashley Li Kuan Ong, et al.
Head & Neck|February 6, 2021
Phase II study of nimotuzumab (TheraCim-hR3) concurrent with cisplatin/radiotherapy in patients with locally advanced head and neck squamous cell carcinomaMei-Kim Ang, Jose Enrique Montoya, Ekkasit Tharavichitkul, et al.
The American Journal of Nursing|February 8, 2023
Impact of a Bedside Activity Device on the Functional Status of Hospitalized Older Adults: A Randomized Controlled TrialPeijin Esther Monica Fan, Joshua Kenneth Louis, Xin Yi Cindy Lim, et al.
Asia-Pacific Journal of Clinical Oncology|October 19, 2016
Prognostic significance of KIT exon 11 deletion mutation in intermediate-risk gastrointestinal stromal tumorRichard Quek, Mohamad Farid, Yada Kanjanapan, et al.
Frontiers in Oncology|April 18, 2022
The Impact of Statin Use and Breast Cancer Recurrence - A Retrospective Study in SingaporeYirong Sim, Cindy Lim, Nitar Phyu, et al.
Pageof 5